Disposition of captopril in normal subjects
- PMID: 6989546
- DOI: 10.1038/clpt.1980.90
Disposition of captopril in normal subjects
Abstract
The disposition of captopril, an angiotensin-converting enzyme inhibitor with antihypertensive properties, was studied in 10 normal male subjects after a single 100-mg tablet of 35S-labeled drug. Average absorption parameters for unchanged captopril in blood were Tmax 0.93 +/- 0.08 hr and Cmax 800 +/- 76 ng/ml. For total radioactivity in blood the values were Tmax 1.05 +/- 0.08 hr and Cmax 1,580 +/- 90 ng/ml (as captopril equivalents). Because of the curvilinearity of the semilogarithmic plots of blood concentrations of captopril:time, elimination half-life (t1/2) of unchanged drug could not be determined. At 1 hr unchanged captopril accounted for about 52% of total radioactivity in blood, and the dimeric disulfide metabolite of captopril accounted for about 10%. In the first 5 days after dosing, an average of about 68% of the radioactive dose was recovered in urine and 18% in feces. The distribution of radioactivity in the first 24-hr urine sample (66% of the dose) was 58% captopril (38% of dose), 2% captopril disulfide (1.5% of dose), and 40% unidentified polar metabolites (26% of dose).
Similar articles
-
Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.Clin Pharmacokinet. 1985 Sep-Oct;10(5):377-91. doi: 10.2165/00003088-198510050-00001. Clin Pharmacokinet. 1985. PMID: 2994938 Review.
-
Captopril kinetics.Clin Pharmacol Ther. 1982 Apr;31(4):452-8. doi: 10.1038/clpt.1982.59. Clin Pharmacol Ther. 1982. PMID: 7037265
-
Pharmacokinetics of captopril in dogs and monkeys.J Pharm Sci. 1981 Oct;70(10):1108-12. doi: 10.1002/jps.2600701005. J Pharm Sci. 1981. PMID: 7028947
-
Blood concentration and urinary excretion of captopril (SQ 14,225) in patients with chronic renal failure.Hypertension. 1981 Jul-Aug;3(4):456-9. doi: 10.1161/01.hyp.3.4.456. Hypertension. 1981. PMID: 7030952
-
Captopril: pharmacology, metabolism and disposition.Drug Metab Rev. 1984;15(4):841-69. doi: 10.3109/03602538409041080. Drug Metab Rev. 1984. PMID: 6437780 Review.
Cited by
-
Cardiovascular drugs in children. II. Angiotensin-converting enzyme inhibitors in pediatric patients.Pediatr Cardiol. 1990 Oct;11(4):199-207. doi: 10.1007/BF02238367. Pediatr Cardiol. 1990. PMID: 2274447 Review. No abstract available.
-
Estimate of volume/flow ratio of gastrointestinal (GI) fluids in humans using pharmacokinetic data.Pharm Res. 1990 May;7(5):518-22. doi: 10.1023/a:1015825018361. Pharm Res. 1990. PMID: 2367321
-
Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.Clin Pharmacokinet. 1985 Sep-Oct;10(5):377-91. doi: 10.2165/00003088-198510050-00001. Clin Pharmacokinet. 1985. PMID: 2994938 Review.
-
Maintenance of the antihypertensive efficacy of captopril despite consistent reduction in daily dosage.Br J Clin Pharmacol. 1982;14 Suppl 2(Suppl 2):81S-85S. doi: 10.1111/j.1365-2125.1982.tb02062.x. Br J Clin Pharmacol. 1982. PMID: 6753909 Free PMC article.
-
The effect of chronic renal failure on drug metabolism and transport.Expert Opin Drug Metab Toxicol. 2008 Aug;4(8):1065-74. doi: 10.1517/17425255.4.8.1065. Expert Opin Drug Metab Toxicol. 2008. PMID: 18680441 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources